Altered MSTN and adipokine secretion may contribute to several clinical complications observed in individuals with PWS, including insulin resistance/diabetes, and is implicated in visceral fat accumulation, low muscle mass, and muscle weakness [15,47,48]. This evidence concerns the gene MSTN and Insulin resistance.